FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

708808004: Lixisenatide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3037137016 Lixisenatide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3037480017 Lixisenatide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
52781000195118 lixisenatide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
821181000172118 lixisénatide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
67631000195118 Lixisenatid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lixisenatide Is a Glucagon-like peptide 1 receptor agonist true Inferred relationship Some
Lixisenatide This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin false Inferred relationship Some
Lixisenatide This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Glucagon-like peptide 1 receptor agonist true Inferred relationship Some
Lixisenatide Is a Polypeptide true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing lixisenatide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lixisenatide Inferred relationship Some 1
Lixisenatide-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lixisenatide Inferred relationship Some 1
Lixisenatide only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lixisenatide Inferred relationship Some 1
Lixisenatide only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lixisenatide Inferred relationship Some 1

This concept is not in any reference sets

Back to Start